Retrievable IVC Filters Left in Too Long Causing Problems
Category: IVC Filters
More Info: Defective Medical Devices
Retrievable IVC Filters meant to be a temporary solution to pulmonary embolism risks in many situation do not get removed or become impossible to remove leading to additional serious complications.
For patients who have suffered a traumatic injury or who are undergoing voluntary or emergency surgery, inferior vena cava (IVC) filters can help trap blood clots that may break free from the lower extremities, and prevent them from traveling to the heart and lungs, where they can cause serious complications.
The filters are implanted in the inferior vena cava – the largest vein in the body – and feature a cage-like construction that, while designed to capture blood clots, allows deoxygenated blood to continue to flow around the device and return to the right atrium of the heart. Blood clot filters are intended to reduce the risk of stroke, pulmonary embolism, and other serious medical conditions, but it’s also important to be aware of their risks.
Continue reading...
See the original article here: https://www.prnewswire.com/news-releases/retrievable-ivc-filters-in-many-cases-are-left-in-too-long-and-become-difficult-or-impossible-to-remove-300249659.html
About TriMark Legal Funding
TriMark Legal Funding was founded in 2003 and is one of America's top rated lawsuit loan companies. TriMark provides pre-settlement funding and post-settlement funding, sometimes called 'lawsuit loans', to injured plaintiffs throughout the United States. We offer funding on hundreds of different types of legal claims including personal injury loans, employment litigation funding, work injury accident loans, workers compensation loans, mass tort litigation funding, and multidistrict litigation funding.
We also provide immediate inheritance advance funding for heirs and beneficiaries, as well as post-settlement legal fee financing for attorneys and law firm loans for legal practices.
Personal Injury Lawsuits | Other Funding Types |
Click here to see the original article.